Clinical Trials Logo

Clinical Trial Summary

CT signs that are evocative of lung COVID-19 infections have been extensively described, whereas 18F-FDG-PET signs have not. Our current study aimed to identify specific COVID-19 18F-FDG-PET signs in patients that were (i) suspected to have a lung infection based on 18F-FDG-PET/CT recorded during the COVID-19 outbreak and (ii) whose COVID-19 diagnosis was definitely established or excluded by appropriate viral testing.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04512118
Study type Observational
Source Central Hospital, Nancy, France
Contact
Status Completed
Phase
Start date March 15, 2020
Completion date July 30, 2020